"Neutropenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A decrease in the number of NEUTROPHILS found in the blood.
| Descriptor ID |
D009503
|
| MeSH Number(s) |
C15.378.553.546.184.564
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neutropenia".
Below are MeSH descriptors whose meaning is more specific than "Neutropenia".
This graph shows the total number of publications written about "Neutropenia" by people in this website by year, and whether "Neutropenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 5 | 6 |
| 1997 | 0 | 2 | 2 |
| 1998 | 2 | 4 | 6 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 5 | 5 |
| 2002 | 2 | 5 | 7 |
| 2003 | 0 | 5 | 5 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 3 | 3 |
| 2006 | 1 | 2 | 3 |
| 2007 | 2 | 4 | 6 |
| 2008 | 1 | 5 | 6 |
| 2009 | 2 | 2 | 4 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 3 | 3 |
| 2012 | 1 | 4 | 5 |
| 2013 | 3 | 2 | 5 |
| 2014 | 2 | 3 | 5 |
| 2015 | 2 | 2 | 4 |
| 2016 | 3 | 5 | 8 |
| 2017 | 0 | 2 | 2 |
| 2018 | 3 | 5 | 8 |
| 2019 | 1 | 2 | 3 |
| 2020 | 2 | 1 | 3 |
| 2021 | 3 | 2 | 5 |
| 2022 | 0 | 1 | 1 |
| 2023 | 3 | 1 | 4 |
| 2024 | 2 | 1 | 3 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neutropenia" by people in Profiles.
-
Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703). JAMA. 2026 Sep 01; 336(9):746-754.
-
Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function. Blood Adv. 2026 Mar 24; 10(6):1967-1976.
-
Molecular and Clinical Characterization of a Founder Mutation Causing G6PC3 Deficiency. J Clin Immunol. 2024 12 04; 45(1):53.
-
Use of letermovir for cytomegalovirus primary prophylaxis in lung transplant recipients. Transpl Infect Dis. 2024 Oct; 26(5):e14337.
-
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. Am J Hematol. 2024 04; 99(4):615-624.
-
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study. Lancet Oncol. 2024 01; 25(1):29-45.
-
Incidence of Acute Cellular Rejection After Granulocyte Colony-Stimulating Factor in Lung Transplant Recipients. J Pharm Pract. 2024 Aug; 37(4):830-837.
-
Temperature Trajectory Subphenotypes in Oncology Patients with Neutropenia and Suspected Infection. Am J Respir Crit Care Med. 2023 05 15; 207(10):1300-1309.
-
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. Clin Cancer Res. 2023 01 04; 29(1):50-59.
-
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes. Am J Hematol. 2023 02; 98(2):272-281.